Tigatuzumab Biosimilar: Harnessing DR5 for Targeted Cancer Therapy Tigatuzumab is a monoclonal antibody targeting death receptor 5 (DR5), a member of the … read more 17th Dec 2025 Shanza Riaz
Vopratelimab: Unlocking the Potential of ICOS in Cancer Research What You Need to Know About VopratelimabWhat is Vopratelimab?Vopratelimab is an experi … read more 15th Jan 2025 Miren Ruiz de Eguilaz
Brentuximab: Unveiling the Role of Anti-CD30 in Cancer Research Key Facts About BrentuximabWhat is Brentuximab?Brentuximab is a monoclonal antibody ta … read more 15th Jan 2025 Marina Alberto